Flow cytometric analysis of deoxyribonucleic acid in human granulosa cells as a function of chronological age and ovulation induction regimen.
We examined whether the proliferative index of granulosa cells as determined by flow cytometry varied with a women's age or ovulation induction regimen that included leuprolide acetate (LA). This prospective cohort study included three groups of patients undergoing assisted reproductive technologies. Group I consisted of 9 women age less than or equal to 30 yr, who received LA plus human menopausal gonadotropin (hMG). Group II included 9 women age more than or equal to 40 yr, who received LA plus hMG. Group III consisted of 6 women age less than or equal to 30 yr who received hMG alone. A total of 79 preovulatory follicles containing greater than 10(4) granulosa cells were obtained from these 24 women and examined by flow cytometry. Group I was compared to group II to match for ovulation induction regimen and to examine proliferative index as a function of age. Group I was compared to group III to match for age and to examine proliferative index as a function of ovulation induction regimen. Outcome measures included proliferative index of granulosa cells as a function of age, ovulation induction regimen, ampules of hMG, estradiol on day of hCG, and serum FSH. Group I demonstrated a greater proliferative index than group II: 23.4% +/- 1.4 vs. 18.4% +/- 0.96 (P less than 0.01). Group I had a greater proliferative index than group III: 23.4% +/- 1.4 vs. 11.9 +/- 0.61 (P less than 0.001). Although both age and the presence of LA appeared to affect the PI, multiple linear regression demonstrated that only the addition of LA and not age, per se, had an independent effect upon granulosa cells undergoing proliferation (P less than 0.0005). We conclude that LA followed by hMG leads to an increase in the percentage of granulosa cells undergoing proliferation when compared to ovulation induction regimens that include hMG alone. Chronological age does not appear to have a significant independent influence upon the proliferative index.
Seifer
D B
DB
Department of Obstetrics and Gynecology, Yale University School of Medicine, New Haven, Connecticut 06510.
Honig
J
J
Penzias
A S
AS
Lavy
G
G
Nadkarni
P M
PM
Jones
E E
EE
DeCherney
A H
AH
Flynn
S D
SD
D000328:Adult; D000375:Aging / Q000378:metabolism*; D002452:Cell Count; D002453:Cell Cycle; D006063:Chorionic Gonadotropin / Q000494:pharmacology; D002970:Cleavage Stage, Ovum; D004247:DNA / Q000032:analysis*; D004958:Estradiol / Q000097:blood; D005260:Female; D005434:Flow Cytometry; D006107:Granulosa Cells / Q000737:chemistry* / Q000166:cytology; D006801:Humans; D016729:Leuprolide / Q000494:pharmacology; D008596:Menotropins / Q000494:pharmacology; D009865:Oocytes / Q000166:cytology; D010062:Ovulation Induction; D012044:Regression Analysis; D013048:Specimen Handling
D006063:Chorionic Gonadotropin; D004958:Estradiol; D008596:Menotropins; D004247:DNA; D016729:Leuprolide